VALUE OF BIOCHEMICAL URINARY MARKERS IN DIAGNOSIS AND PROGNOSIS OF BLADDER CANCER PATIENTS

Changes Of P21 And Bcl-2 During Induction Of Bladder Inflammation And/Or Bladder Carcinogenesis

piRABC and TNFSF4 as biomarkers for diagnosis and staging of bladder cancer.

Evaluation of Minichromosome Maintenance Deficient-5 Levels in non-Muscle invasive Bladder Cancer Patients

c-erbB-2 EXPRESSION IN INVASIVE TRANSITIONAL AND SQUAMOUS CELL CARCINOMA OF THE SCHISTOSOMAL URINARY BLADDER:AN IMMUNOHISTOCHEMICAL AND CLINICAL STUDY

PROGNOSTIC VALUE OF PD-L1 TUMOR EXPRESSION IN EGYPTIAN PATIENTS WITH EPITHELIAL BLADDER CANCER

Using of Telomerase Enzyme in Urine as a Non invasive Marker for Cancer Bladder Detection

Assessment of PD-L1 and p53 expression in urinary bladder carcinoma: Association with different clinicopathologic characteristics

CD44 and p53 co-expression in high grade, muscle invasive bladder urothelial carcinoma with and without schistosomiasis

Immunohistochemical Study of the Role of CK20, p53 and Ki-67 in Differentiation of Some Urothelial Lesions and Urothelial Carcinoma of the Urinary Bladder